13FPulse
中
CA

CAPR CAPRICOR THERAPEUTICS INC

2026Q2 · CUSIP 14070B309 · Sector: Healthcare & Biotech

Exiting + falling

Funds leaving and price falling — historically weak for the next six months

Funds that own it
167
Institutions that reported holding it to the SEC
Net decrease in holders
9
Last quarter 176 → now 167
How unusual is that
Bottom 20%
Stronger than only 14% of US stocks
What the filings say, in one paragraph

167 funds held CAPR at the end of 2026Q2, down 9 from the quarter before. Buying is stronger than only 14.2% of US stocks, and the price fell over the same quarter — funds leaving and price weakness at the same time. On the business itself, return on equity is -52.6%. CAPR has had 4 buying rushes in its history, and the price moved -48.4% on average over the six months after (that is the raw price move, not how much it beat the market by). It sits in the Healthcare & Biotech sector.

How many funds owned it, quarter by quarter

Bars = net change in institutional holders, positive (green) or negative (red). Line = total institutional holders.

2019Q3: holders=15 2019Q4: holders=18 2020Q1: holders=19 2020Q2: holders=33 2020Q3: holders=25 2020Q4: holders=25 2021Q1: holders=30 2021Q2: holders=31 2021Q3: holders=30 2021Q4: holders=25 2022Q1: holders=28 2022Q2: holders=30 2022Q3: holders=31 2022Q4: holders=31 2023Q1: holders=30 2023Q2: holders=32 2023Q3: holders=34 2023Q4: holders=37 2024Q1: holders=57 2024Q2: holders=61 2024Q3: holders=75 2024Q4: holders=108 2025Q1: holders=122 2025Q2: holders=106 2025Q3: holders=115 2025Q4: holders=132 2026Q1: holders=176 2026Q2: holders=167 -44 -22 +0 +22 +44 1399185 19Q320Q221Q121Q422Q323Q224Q124Q425Q326Q2 Net change in holders (bars) Total funds holding (line)

What happened after each past buying rush 4 times in its history

Quarter of the rush How unusual then Price, next 3 months Price, next 6 months
2026Q1 Top 10% — —
2025Q1 Top 20% -26.0% -45.1%
2024Q4 Top 20% -40.8% -51.7%
2024Q1 Top 20% — —

These are the raw price moves, not how much it beat the market by. Compare them against the market over the same months — in a strong bull market almost everything is up.

Show all the numbers (large funds, value held, options…) ▾
Of them, large funds
95
Change in large funds
-1
Total value they hold
$922M
Funds buying for the first time
31
Funds that sold out entirely
40
Price change that quarter
-64.3%
Funds holding puts (bearish)
10
Funds holding calls (bullish)
15

These are for people who want to dig. Skip them if they do not mean anything to you — the three numbers above are enough.

8,697 institutions have filed for this quarter. 13F permits late filing and a small number arrive in the weeks after the deadline, so the holder counts and changes below may tick up.

Fundamentals

PE (TTM)
—
EPS (TTM)
$-2.45
EPS YoY
—
Revenue (TTM)
—
Revenue YoY
—
Net margin
—
ROE
-52.6%
Debt ratio
33.2%
FCF (TTM)
-$115M
Dividend (TTM)
No dividend
Quarterly Revenue & EPS
2021-09-30: EPS -0.17 2021-12-31: EPS -0.26 2022-03-31: EPS -0.32 2022-06-30: EPS -0.29 2022-09-30: EPS -0.26 2022-12-31: EPS -0.31 2023-03-31: EPS -0.31 2023-06-30: EPS -0.29 2023-09-30: EPS -0.25 2023-12-31: EPS 0.02 2024-03-31: EPS -0.31 2024-06-30: EPS -0.35 2024-09-30: EPS -0.38 2024-12-31: EPS -0.11 2025-03-31: EPS -0.53 2025-06-30: EPS -0.57 2025-09-30: EPS -0.54 2025-12-31: EPS -0.62 2026-03-31: EPS -0.59 2026-06-30: EPS -0.70 -0.77 -0.37 0.02 20212022202320242025202606/26 EPS

Quarterly figures, revenue up to 10 years back; EPS split-adjusted, early quarters hidden when not calibrable

Quarterly free cash flow
-34M-5M23M 20162017201820192020202120222023202420252026
Latest quarter $-34M (2026-03-31)

FCF = operating cash flow − capex, computed from SEC XBRL; banks/insurers have no standard cash-flow structure and are hidden

As of 2026-06-30 · SEC filings (XBRL)

Email me the next update

2026 Q3 holdings are due 2026-11-16. We will email you when the refreshed lists are live.